4.7 Review

The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition

Giulia Rizzo et al.

Summary: This study investigated the tissue changes in perianal fistula and explored the dysregulation of extracellular matrix (ECM) homeostasis in fistula formation. They found that TNFAI6 (encoding TSG-6) was significantly upregulated in the fistula and played a role in the formation of a crosslinked ECM. TSG-6 mediated changes in ECM organization and triggered the activation of the epithelial-mesenchymal transition transcription factor SNAI1 through mechano-sensitive proteins.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Characterization of prokineticin system in Crohn's disease pathophysiology and pain, and its modulation by alcohol abuse: A preclinical study

Giada Amodeo et al.

Summary: The prokineticin system (PKS) plays an important role in the pathophysiology and pain of Crohn's disease (CD). TNBS-model experiments showed that the expression of PKS and inflammation/neuroinflammation-related genes significantly increased in CD mice. Additionally, alcohol abuse may be a triggering factor for CD by activating PKS and exacerbating inflammation/neuroinflammation.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

Article Multidisciplinary Sciences

Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods

Zi-An Chen et al.

Summary: Crohn's disease (CD) is a complex autoimmune disorder influenced by genetic, immune, microbial, and environmental factors. Machine learning is used to identify biomarkers for diagnosis and treatment. Analysis of CD datasets in Gene Expression Omnibus (GEO) revealed differentially expressed genes (DEGs) which were further analyzed through protein-protein interaction (PPI) network and functional enrichment analyses. Machine learning algorithms were applied to determine characteristic genes, which were validated using ROC analysis and immunohistochemistry (IHC).

SCIENTIFIC REPORTS (2023)

Article Cell Biology

Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model

Giulia Galimberti et al.

Summary: This study examined the role of the Prokineticin system in OA pain and mood disorders. The results showed that a PK antagonist could reduce arthritis and neuroinflammation, and alleviate pain and emotional disturbances.

CELLS (2023)

Article Biology

Prokineticin-Receptor Network: Mechanisms of Regulation

Roberta Lattanzi et al.

Summary: This review summarizes the major cellular and biochemical mechanisms of prokineticins pathway regulation and discusses the potential for therapeutic intervention.

LIFE-BASEL (2022)

Review Oncology

Inflammatory bowel disease and carcinogenesis

Hiroko Nagao-Kitamoto et al.

Summary: Colorectal cancer is the third most common cancer worldwide and is closely associated with ulcerative colitis. Patients with ulcerative colitis have 2-3 times higher risk of developing colorectal cancer compared to those without the disease. Chronic inflammation is believed to be a major factor contributing to the development of colorectal cancer. Understanding the mechanisms by which inflammation triggers genetic alterations and disrupts intestinal homeostasis may lead to novel therapeutic strategies for the prevention of colorectal cancer.

CANCER AND METASTASIS REVIEWS (2022)

Article Neurosciences

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases

Daniela Maftei et al.

Summary: The immune system plays a crucial role in neurodegenerative diseases, and the chemokine PK2 is an important player in these diseases. The potential clinical value of PK2 as a disease biomarker or therapeutic target for Alzheimer's disease and Parkinson's disease is discussed.

CURRENT NEUROPHARMACOLOGY (2022)

Review Gastroenterology & Hepatology

Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment

Tania H. Bisgaard et al.

Summary: This review summarizes the co-occurrence of inflammatory bowel disease (IBD) with depression and anxiety, as well as the temporal relationship between these diseases. The review also explores the impact of psychological stress on the onset and course of IBD, and discusses the potential mechanisms underlying the co-occurrence of IBD with depression and anxiety. Additionally, the review examines the effects of treatment for depression and anxiety on the risk and course of IBD.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Oncology

Prokineticin 2 in cancer-related inflammation

Roberta Lattanzi et al.

Summary: Inflammation plays a crucial role in tumor progression. Prokineticin 2 is involved in tumor growth, angiogenesis, and metastasis. In addition to its function as an angiogenic factor and a mediator of immune cell migration, prokineticin 2 also suppresses tumor cell apoptosis, promotes their proliferation and movements necessary for metastasis. It is also associated with tumor pain and resistance responses, and may serve as a potential prognostic tumor biomarker.

CANCER LETTERS (2022)

Review Biochemistry & Molecular Biology

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors

Roberta Lattanzi et al.

Summary: The prokineticin family is a group of secreted peptides classified as chemokines based on their structure and functions. Prokineticins bind with high affinity to two G protein-coupled receptors and play important roles in various physiological functions. Dysregulation of the system leads to inflammatory processes associated with many pathological conditions. The use of PKR antagonists can reduce the upregulation of PK2/PKRs triggered by inflammatory processes, suggesting a potential strategy for treating inflammatory/neuroinflammatory diseases.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Interplay between Prokineticins and Histone Demethylase KDM6A in a Murine Model of Bortezomib-Induced Neuropathy

Laura Rullo et al.

Summary: Chemotherapy-induced neuropathy is associated with various chemotherapeutics, including bortezomib. Recent studies have shown the involvement of epigenetic mechanisms and prokineticins (PKs) in the pathogenesis of painful neuropathy induced by bortezomib in mice. PKs play a role in maintaining the increase of proinflammatory cytokines and regulating the expression of PPARs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study

Noriyuki Tagai et al.

Summary: Prokineticin 1 (PROK1) expression in preoperative plasma is associated with poor prognosis in colorectal cancer patients undergoing curative resection. Plasma PROK1 levels may serve as a potential predictive marker, especially in stage III colorectal cancer patients.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)

Review Pharmacology & Pharmacy

The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes

Roberta Lattanzi et al.

Summary: The Prokineticin family, specifically Prokineticin 1 and Bv8/Prokineticin 2 (PROK2), interact with G protein-coupled receptors to regulate various biological functions in the central nervous system. Pathological insults can increase PROK2 expression levels and potentially contribute to neurodegenerative diseases. Despite documented physiological effects, the role of PROK2 and its receptors in neuropathological conditions remains unclear.

FRONTIERS IN PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Marianna Lucafo et al.

Summary: This passage discusses the increased risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients, highlighting the potential different tumorigenesis pathway of IBD-associated CRC (IBD-CRC) compared to sporadic CRC. It also emphasizes the important role of immunomodulators and biologics in interfering with the inflammatory process involved in carcinogenesis for treating IBD patients.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

The Antagonism of the Prokineticin System Counteracts Bortezomib Induced Side Effects: Focus on Mood Alterations

Giada Amodeo et al.

Summary: The study indicates that mice treated with the proteasome inhibitor bortezomib may develop anxiety and depression, which are related to neuroinflammation and prokineticin system activation. Treatment with the prokineticin system antagonist PC1, which has anti-pain and anti-neuroinflammation effects, can prevent mood alterations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Nutrition & Dietetics

Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain

Muhammad Nazirul Mubin Aziz et al.

Summary: Patients with irritable bowel syndrome (IBS) exhibit a wide range of neuropsychiatric symptoms, with functional imaging revealing abnormalities in various brain regions. The gut-brain axis research shows the important role of gut microbiota in maintaining the balance of the gastrointestinal and central nervous systems.

NUTRIENTS (2021)

Review Gastroenterology & Hepatology

Abnormal gut motility in inflammatory bowel disease: an update

G. Bassotti et al.

TECHNIQUES IN COLOPROCTOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Global burden of inflammatory bowel disease

Vipul Jairath et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Pharmacology & Pharmacy

Cytokines in inflammatory bowel diseases - Update 2020

M. Leppkes et al.

PHARMACOLOGICAL RESEARCH (2020)

Review Immunology

Resolution of ulcerative colitis

Markus F. Neurath et al.

SEMINARS IN IMMUNOPATHOLOGY (2019)

Review Gastroenterology & Hepatology

Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment

Luisa Leite Barros et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis

Manisha Bajpai et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Review Gastroenterology & Hepatology

Environmental triggers in IBD: a review of progress and evidence

Ashwin N. Ananthakrishnan et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Clinical Neurology

The prokineticin system: an interface between neural inflammation and pain

Silvia Franchi et al.

NEUROLOGICAL SCIENCES (2017)

Review Immunology

Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation

Felipe A. Pinho-Ribeiro et al.

TRENDS IN IMMUNOLOGY (2017)

Article Gastroenterology & Hepatology

IBS and IBD - separate entities or on a spectrum?

Robin Spiller et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

How to predict clinical relapse in inflammatory bowel disease patients

Elisa Liverani et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

The global burden of IBD: from 2015 to 2025

Gilaad G. Kaplan

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Review Immunology

Angiogenesis in Inflammatory Bowel Disease

Canan Alkim et al.

INTERNATIONAL JOURNAL OF INFLAMMATION (2015)

Review Immunology

Innate and adaptive immunity in inflammatory bowel disease

Alessandra Geremia et al.

AUTOIMMUNITY REVIEWS (2014)

Article Integrative & Complementary Medicine

Mild Moxibustion Decreases the Expression of Prokineticin 2 and Prokineticin Receptor 2 in the Colon and Spinal Cord of Rats with Irritable Bowel Syndrome

Cili Zhou et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)

Article Gastroenterology & Hepatology

Inflammatory bowel disease: Pathogenesis

Yi-Zhen Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Gastrointestinal motility disorders in inflammatory bowel diseases

Gabrio Bassotti et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Immunology

Cytokines in inflammatory bowel disease

Markus F. Neurath

NATURE REVIEWS IMMUNOLOGY (2014)

Review Gastroenterology & Hepatology

Gastrointestinal infection as a trigger for inflammatory bowel disease

Elizabeth A. Mann et al.

CURRENT OPINION IN GASTROENTEROLOGY (2012)

Article Gastroenterology & Hepatology

Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport

Robert P. Watson et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2012)

Article Gastroenterology & Hepatology

Intestinal Inflammation and Cancer

Thomas A. Ullman et al.

GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status

Robert V. Bryant et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)

Review Gastroenterology & Hepatology

Pain and Inflammatory Bowel Disease

Klaus Bielefeldt et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Enteric neuroglial apoptosis in inflammatory bowel diseases

Gabrio Bassotti et al.

JOURNAL OF CROHNS & COLITIS (2009)

Article Multidisciplinary Sciences

The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain

Elisa Giannini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Cardiac & Cardiovascular Systems

Prokineticin Receptors in Cardiovascular Function: Foe or Friend?

Canan G. Nebigil

TRENDS IN CARDIOVASCULAR MEDICINE (2009)

Review Biochemistry & Molecular Biology

Cytokine properties of prokineticins

Justin Monnier et al.

FEBS JOURNAL (2008)

Article Biochemistry & Molecular Biology

Prokineticin-signaling pathway

Elly S. W. Ngan et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)

Article Gastroenterology & Hepatology

Enteric nervous system abnormalities in inflammatory bowel diseases

V. Villanacci et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2008)

Article Gastroenterology & Hepatology

Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis

E. S. Kimball et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2007)

Article Biochemistry & Molecular Biology

Prokineticin-1 modulates proliferation and differentiation of enteric neural crest cells

Elly S. W. Ngan et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)

Review Medical Laboratory Technology

Immune dysfunction in inflammatory bowel disease

Manuela G. Neuman

TRANSLATIONAL RESEARCH (2007)

Article Neurosciences

Impaired pain sensation in mice lacking prokineticin 2

Wang-Ping Hu et al.

MOLECULAR PAIN (2006)

Review Neurosciences

Modulators of pain: BV8 and prokineticins

Lucia Negri et al.

CURRENT NEUROPHARMACOLOGY (2006)

Article Gastroenterology & Hepatology

Prokineticin 1 inhibits spontaneous giant contractions in the murine proximal colon through nitric oxide release

W. A. Hoogerwerf

NEUROGASTROENTEROLOGY AND MOTILITY (2006)

Article Neurosciences

Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8

Vittorio Vellani et al.

JOURNAL OF NEUROSCIENCE (2006)

Article Pharmacology & Pharmacy

Prokineticin-2, motilin, ghrelin and metoclopramide: Prokinetic utility in mouse stomach and colon

AK Bassil et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2005)

Article Cell Biology

PK1/EG-VEGF induces monocyte differentiation and activation

M Dorsch et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2005)

Article Multidisciplinary Sciences

Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization

J LeCouter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Biochemistry & Molecular Biology

The AVIT protein family - Secreted cysteine-rich vertebrate proteins with diverse functions

A Kaser et al.

EMBO REPORTS (2003)

Article Pharmacology & Pharmacy

Nociceptive sensitization by the secretory protein Bv8

L Negri et al.

BRITISH JOURNAL OF PHARMACOLOGY (2002)

Article Multidisciplinary Sciences

Identification of an angiogenic mitogen selective for endocrine gland endothelium

J LeCouter et al.

NATURE (2001)

Review Gastroenterology & Hepatology

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

JA Eaden et al.